Arrow Financial Corp lifted its stake in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 81.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,225 shares of the medical research company’s stock after buying an additional 1,897 shares during the quarter. Arrow Financial Corp’s holdings in Thermo Fisher Scientific were worth $800,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently added to or reduced their stakes in the company. Amalgamated Bank grew its position in shares of Thermo Fisher Scientific by 57.0% during the second quarter. Amalgamated Bank now owns 44,921 shares of the medical research company’s stock worth $7,837,000 after buying an additional 16,308 shares in the last quarter. BB&T Securities LLC boosted its holdings in Thermo Fisher Scientific by 4.4% in the first quarter. BB&T Securities LLC now owns 89,837 shares of the medical research company’s stock worth $13,798,000 after purchasing an additional 3,819 shares during the period. Mutual of America Capital Management LLC boosted its holdings in Thermo Fisher Scientific by 2.1% in the second quarter. Mutual of America Capital Management LLC now owns 47,728 shares of the medical research company’s stock worth $8,327,000 after purchasing an additional 977 shares during the period. Mitchell Capital Management Co. boosted its holdings in Thermo Fisher Scientific by 40.3% in the second quarter. Mitchell Capital Management Co. now owns 44,940 shares of the medical research company’s stock worth $7,841,000 after purchasing an additional 12,910 shares during the period. Finally, State Board of Administration of Florida Retirement System boosted its holdings in Thermo Fisher Scientific by 0.9% in the second quarter. State Board of Administration of Florida Retirement System now owns 580,712 shares of the medical research company’s stock worth $101,317,000 after purchasing an additional 5,213 shares during the period. 83.78% of the stock is owned by institutional investors and hedge funds.

In other Thermo Fisher Scientific news, Director C Martin Harris sold 360 shares of the business’s stock in a transaction dated Wednesday, August 30th. The shares were sold at an average price of $180.97, for a total value of $65,149.20. Following the sale, the director now directly owns 5,312 shares in the company, valued at $961,312.64. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Jim P. Manzi sold 11,318 shares of the business’s stock in a transaction dated Friday, August 18th. The stock was sold at an average price of $172.94, for a total transaction of $1,957,334.92. Following the completion of the sale, the director now owns 38,757 shares in the company, valued at $6,702,635.58. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 22,738 shares of company stock worth $4,021,512. Company insiders own 0.49% of the company’s stock.

Shares of Thermo Fisher Scientific Inc (NYSE:TMO) opened at $188.21 on Tuesday. Thermo Fisher Scientific Inc has a one year low of $139.07 and a one year high of $201.20. The company has a current ratio of 1.26, a quick ratio of 0.81 and a debt-to-equity ratio of 0.85. The firm has a market cap of $74,657.32, a PE ratio of 20.46, a P/E/G ratio of 1.71 and a beta of 1.08.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Wednesday, October 25th. The medical research company reported $2.31 earnings per share for the quarter, beating analysts’ consensus estimates of $2.24 by $0.07. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. The business had revenue of $5.12 billion for the quarter, compared to analysts’ expectations of $5.03 billion. During the same period in the previous year, the business earned $2.03 earnings per share. The company’s revenue was up 13.9% on a year-over-year basis. research analysts predict that Thermo Fisher Scientific Inc will post 9.36 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Investors of record on Friday, December 15th will be paid a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.32%. The ex-dividend date is Thursday, December 14th. Thermo Fisher Scientific’s dividend payout ratio is currently 10.19%.

A number of equities analysts have commented on TMO shares. Leerink Swann lifted their price objective on shares of Thermo Fisher Scientific from $190.00 to $207.00 and gave the stock an “outperform” rating in a report on Monday, October 9th. Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $212.00 price objective for the company in a report on Thursday, September 21st. Bank of America Corporation reaffirmed a “buy” rating and issued a $210.00 price objective (up previously from $200.00) on shares of Thermo Fisher Scientific in a report on Friday, July 21st. Cowen and Company reaffirmed an “outperform” rating and issued a $220.00 price objective (up previously from $200.00) on shares of Thermo Fisher Scientific in a report on Sunday, September 10th. Finally, Deutsche Bank AG set a $226.00 price objective on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a report on Thursday, October 26th. One research analyst has rated the stock with a hold rating and sixteen have given a buy rating to the company. Thermo Fisher Scientific has an average rating of “Buy” and an average price target of $205.71.

TRADEMARK VIOLATION NOTICE: “Arrow Financial Corp Has $800,000 Stake in Thermo Fisher Scientific Inc (TMO)” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another website, it was copied illegally and reposted in violation of US and international copyright legislation. The correct version of this report can be accessed at https://www.thecerbatgem.com/2017/11/14/arrow-financial-corp-has-800000-stake-in-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Stock Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related stocks with our FREE daily email newsletter.